Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.10
MDRX's Cash-to-Debt is ranked lower than
95% of the 2082 Companies
in the Global Software - Application industry.

( Industry Median: 8.37 vs. MDRX: 0.10 )
Ranked among companies with meaningful Cash-to-Debt only.
MDRX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07  Med: 0.48 Max: No Debt
Current: 0.1
0.07
No Debt
Equity-to-Asset 0.27
MDRX's Equity-to-Asset is ranked lower than
85% of the 1985 Companies
in the Global Software - Application industry.

( Industry Median: 0.60 vs. MDRX: 0.27 )
Ranked among companies with meaningful Equity-to-Asset only.
MDRX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27  Med: 0.59 Max: 0.95
Current: 0.27
0.27
0.95
Debt-to-Equity 1.41
MDRX's Debt-to-Equity is ranked lower than
91% of the 1133 Companies
in the Global Software - Application industry.

( Industry Median: 0.27 vs. MDRX: 1.41 )
Ranked among companies with meaningful Debt-to-Equity only.
MDRX' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.43 Max: 1.41
Current: 1.41
0
1.41
Debt-to-EBITDA 16.36
MDRX's Debt-to-EBITDA is ranked lower than
97% of the 1031 Companies
in the Global Software - Application industry.

( Industry Median: 1.33 vs. MDRX: 16.36 )
Ranked among companies with meaningful Debt-to-EBITDA only.
MDRX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01  Med: 3.17 Max: 16.36
Current: 16.36
0.01
16.36
Interest Coverage 0.48
MDRX's Interest Coverage is ranked lower than
97% of the 1570 Companies
in the Global Software - Application industry.

( Industry Median: 140.00 vs. MDRX: 0.48 )
Ranked among companies with meaningful Interest Coverage only.
MDRX' s Interest Coverage Range Over the Past 10 Years
Min: 0.48  Med: 4.88 Max: 70.62
Current: 0.48
0.48
70.62
Piotroski F-Score: 5
Altman Z-Score: 0.63
Beneish M-Score: -2.56
WACC vs ROIC
6.99%
2.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 2.32
MDRX's Operating Margin % is ranked lower than
59% of the 2027 Companies
in the Global Software - Application industry.

( Industry Median: 4.54 vs. MDRX: 2.32 )
Ranked among companies with meaningful Operating Margin % only.
MDRX' s Operating Margin % Range Over the Past 10 Years
Min: -8.46  Med: 3.29 Max: 14.84
Current: 2.32
-8.46
14.84
Net Margin % -10.88
MDRX's Net Margin % is ranked lower than
75% of the 2027 Companies
in the Global Software - Application industry.

( Industry Median: 3.36 vs. MDRX: -10.88 )
Ranked among companies with meaningful Net Margin % only.
MDRX' s Net Margin % Range Over the Past 10 Years
Min: -10.88  Med: -0.12 Max: 8.92
Current: -10.88
-10.88
8.92
ROE % -17.14
MDRX's ROE % is ranked lower than
77% of the 1969 Companies
in the Global Software - Application industry.

( Industry Median: 6.14 vs. MDRX: -17.14 )
Ranked among companies with meaningful ROE % only.
MDRX' s ROE % Range Over the Past 10 Years
Min: -17.14  Med: -0.13 Max: 8.17
Current: -17.14
-17.14
8.17
ROA % -5.03
MDRX's ROA % is ranked lower than
70% of the 2097 Companies
in the Global Software - Application industry.

( Industry Median: 3.01 vs. MDRX: -5.03 )
Ranked among companies with meaningful ROA % only.
MDRX' s ROA % Range Over the Past 10 Years
Min: -5.03  Med: -0.07 Max: 6.14
Current: -5.03
-5.03
6.14
ROC (Joel Greenblatt) % -76.96
MDRX's ROC (Joel Greenblatt) % is ranked lower than
76% of the 2065 Companies
in the Global Software - Application industry.

( Industry Median: 20.86 vs. MDRX: -76.96 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MDRX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -77.69  Med: 28.79 Max: 171.84
Current: -76.96
-77.69
171.84
3-Year Revenue Growth Rate 9.20
MDRX's 3-Year Revenue Growth Rate is ranked higher than
61% of the 1648 Companies
in the Global Software - Application industry.

( Industry Median: 5.80 vs. MDRX: 9.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MDRX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -28.6  Med: 9.05 Max: 24.3
Current: 9.2
-28.6
24.3
3-Year EBITDA Growth Rate -10.90
MDRX's 3-Year EBITDA Growth Rate is ranked lower than
81% of the 1481 Companies
in the Global Software - Application industry.

( Industry Median: 8.80 vs. MDRX: -10.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MDRX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 10.3 Max: 66.3
Current: -10.9
0
66.3
3-Year EPS without NRI Growth Rate -44.70
MDRX's 3-Year EPS without NRI Growth Rate is ranked lower than
91% of the 1387 Companies
in the Global Software - Application industry.

( Industry Median: 9.80 vs. MDRX: -44.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MDRX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -23.85 Max: 71
Current: -44.7
0
71
GuruFocus has detected 3 Warning Signs with Allscripts Healthcare Solutions Inc MDRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MDRX's 30-Y Financials

Financials (Next Earnings Date: 2018-05-04)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

MDRX Guru Trades in Q2 2017

Jim Simons 504,567 sh (New)
Steven Cohen 557,000 sh (New)
Paul Tudor Jones 56,070 sh (+76.73%)
Michael Price 477,500 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss 1,912 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Chuck Royce 1,870,600 sh (-3.25%)
First Eagle Investment 2,272,020 sh (-26.92%)
» More
Q3 2017

MDRX Guru Trades in Q3 2017

Joel Greenblatt 35,871 sh (New)
Ken Fisher 2,343,733 sh (New)
Paul Tudor Jones 59,276 sh (+5.72%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Steven Cohen Sold Out
First Eagle Investment Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Jim Simons Sold Out
Chuck Royce 1,570,100 sh (-16.06%)
Michael Price 100,000 sh (-79.06%)
» More
Q4 2017

MDRX Guru Trades in Q4 2017

Pioneer Investments 560,841 sh (New)
Joel Greenblatt 57,019 sh (+58.96%)
Chuck Royce 1,629,600 sh (+3.79%)
Ken Fisher 2,386,237 sh (+1.81%)
Paul Tudor Jones Sold Out
Michael Price Sold Out
Vanguard Health Care Fund 9,691,893 sh (-13.46%)
» More
Q1 2018

MDRX Guru Trades in Q1 2018

Ken Fisher 6,501,069 sh (+172.44%)
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2018-03-31 Add 172.44%0.06%$11.97 - $16.03 $ 12.22-14%6,501,069
Vanguard Health Care Fund 2017-12-31 Reduce -13.46%0.05%$12.57 - $14.91 $ 12.22-12%9,691,893
Ken Fisher 2017-12-31 Add 1.81%$12.57 - $14.91 $ 12.22-12%2,386,237
Joel Greenblatt 2017-12-31 Add 58.96%$12.57 - $14.91 $ 12.22-12%57,019
Michael Price 2017-12-31 Sold Out 0.2%$12.57 - $14.91 $ 12.22-12%0
Ken Fisher 2017-09-30 New Buy0.05%$11.67 - $14.24 $ 12.22-5%2,343,733
Michael Price 2017-09-30 Reduce -79.06%0.62%$11.67 - $14.24 $ 12.22-5%100,000
Joel Greenblatt 2017-09-30 New Buy0.01%$11.67 - $14.24 $ 12.22-5%35,871
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Sold Out $11.67 - $14.24 $ 12.22-5%0
First Eagle Investment 2017-09-30 Sold Out 0.07%$11.67 - $14.24 $ 12.22-5%0
First Eagle Investment 2017-06-30 Reduce -26.92%0.03%$11.34 - $12.82 $ 12.221%2,272,020
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Software - Application    NAICS: 541519    SIC: 7373
Compare:SZSE:002280, NAS:TTD, NAS:NTCT, NAS:CSOD, SZSE:300222, TSX:DSG, ASX:ALU, NYSE:AYX, NAS:MANT, XMCE:IDR, NAS:EBIX, NAS:CALD, TSE:2327, NAS:VRNT, SHSE:600718, SHSE:900926, SZSE:300002, NAS:MDB, SHSE:600446, SHSE:600687 » details
Traded in other countries:AL21.Germany,
Headquarter Location:USA
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.

Allscripts Healthcare Solutions, an HCIT vendor, delivers information technology and services to healthcare organizations. The clinical and financial solutions segment sells software applications and financial and information solutions, including electronic health records, practice management software, revenue cycle management, support, and maintenance. The population health segment sells health management and coordinated care solutions to health systems, hospitals, and accountable care organizations. Allscripts is headquartered in Chicago.

Ratios

vs
industry
vs
history
Forward PE Ratio 15.85
MDRX's Forward PE Ratio is ranked higher than
69% of the 318 Companies
in the Global Software - Application industry.

( Industry Median: 24.04 vs. MDRX: 15.85 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 1.97
MDRX's PB Ratio is ranked higher than
66% of the 1923 Companies
in the Global Software - Application industry.

( Industry Median: 3.25 vs. MDRX: 1.97 )
Ranked among companies with meaningful PB Ratio only.
MDRX' s PB Ratio Range Over the Past 10 Years
Min: 0.79  Med: 2.05 Max: 4.75
Current: 1.97
0.79
4.75
PS Ratio 1.21
MDRX's PS Ratio is ranked higher than
69% of the 1917 Companies
in the Global Software - Application industry.

( Industry Median: 2.57 vs. MDRX: 1.21 )
Ranked among companies with meaningful PS Ratio only.
MDRX' s PS Ratio Range Over the Past 10 Years
Min: 0.91  Med: 1.92 Max: 6.46
Current: 1.21
0.91
6.46
Price-to-Free-Cash-Flow 23.42
MDRX's Price-to-Free-Cash-Flow is ranked higher than
55% of the 689 Companies
in the Global Software - Application industry.

( Industry Median: 28.70 vs. MDRX: 23.42 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDRX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.1  Med: 32.35 Max: 3475
Current: 23.42
10.1
3475
Price-to-Operating-Cash-Flow 7.91
MDRX's Price-to-Operating-Cash-Flow is ranked higher than
83% of the 889 Companies
in the Global Software - Application industry.

( Industry Median: 20.00 vs. MDRX: 7.91 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDRX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.78  Med: 18.67 Max: 81.52
Current: 7.91
5.78
81.52
EV-to-EBIT -29.75
MDRX's EV-to-EBIT is ranked lower than
99.99% of the 1329 Companies
in the Global Software - Application industry.

( Industry Median: 20.79 vs. MDRX: -29.75 )
Ranked among companies with meaningful EV-to-EBIT only.
MDRX' s EV-to-EBIT Range Over the Past 10 Years
Min: -380.6  Med: 31.85 Max: 1044
Current: -29.75
-380.6
1044
EV-to-EBITDA 37.72
MDRX's EV-to-EBITDA is ranked lower than
84% of the 1441 Companies
in the Global Software - Application industry.

( Industry Median: 16.23 vs. MDRX: 37.72 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDRX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.4  Med: 22.15 Max: 71
Current: 37.72
7.4
71
EV-to-Revenue 2.00
MDRX's EV-to-Revenue is ranked higher than
55% of the 2002 Companies
in the Global Software - Application industry.

( Industry Median: 2.59 vs. MDRX: 2.00 )
Ranked among companies with meaningful EV-to-Revenue only.
MDRX' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.1  Med: 2.4 Max: 6.8
Current: 2
1.1
6.8
Current Ratio 0.97
MDRX's Current Ratio is ranked lower than
84% of the 1912 Companies
in the Global Software - Application industry.

( Industry Median: 1.96 vs. MDRX: 0.97 )
Ranked among companies with meaningful Current Ratio only.
MDRX' s Current Ratio Range Over the Past 10 Years
Min: 0.91  Med: 1.7 Max: 9.91
Current: 0.97
0.91
9.91
Quick Ratio 0.97
MDRX's Quick Ratio is ranked lower than
81% of the 1912 Companies
in the Global Software - Application industry.

( Industry Median: 1.81 vs. MDRX: 0.97 )
Ranked among companies with meaningful Quick Ratio only.
MDRX' s Quick Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.57 Max: 9.36
Current: 0.97
0.8
9.36
Days Sales Outstanding 114.75
MDRX's Days Sales Outstanding is ranked lower than
78% of the 1642 Companies
in the Global Software - Application industry.

( Industry Median: 68.90 vs. MDRX: 114.75 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDRX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.24  Med: 92.98 Max: 114.75
Current: 114.75
76.24
114.75
Days Payable 34.78
MDRX's Days Payable is ranked lower than
60% of the 1444 Companies
in the Global Software - Application industry.

( Industry Median: 45.06 vs. MDRX: 34.78 )
Ranked among companies with meaningful Days Payable only.
MDRX' s Days Payable Range Over the Past 10 Years
Min: 19.32  Med: 31.41 Max: 52.39
Current: 34.78
19.32
52.39

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.34
MDRX's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
69% of the 789 Companies
in the Global Software - Application industry.

( Industry Median: 2.28 vs. MDRX: 1.34 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDRX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.85  Med: 1.6 Max: 6.76
Current: 1.34
0.85
6.76
Price-to-Median-PS-Value 0.64
MDRX's Price-to-Median-PS-Value is ranked higher than
82% of the 1595 Companies
in the Global Software - Application industry.

( Industry Median: 1.14 vs. MDRX: 0.64 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDRX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61  Med: 1.28 Max: 12.64
Current: 0.64
0.61
12.64
Earnings Yield (Greenblatt) % -3.36
MDRX's Earnings Yield (Greenblatt) % is ranked lower than
75% of the 2098 Companies
in the Global Software - Application industry.

( Industry Median: 1.99 vs. MDRX: -3.36 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDRX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -4.2  Med: 1.5 Max: 5.5
Current: -3.36
-4.2
5.5
Forward Rate of Return (Yacktman) % 19.35
MDRX's Forward Rate of Return (Yacktman) % is ranked higher than
63% of the 834 Companies
in the Global Software - Application industry.

( Industry Median: 10.67 vs. MDRX: 19.35 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MDRX' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -9.9  Med: 7.7 Max: 22.8
Current: 19.35
-9.9
22.8

More Statistics

Revenue (TTM) (Mil) $1,806.34
EPS (TTM) $ -1.09
Beta1.28
Volatility24.78%
52-Week Range $10.78 - 16.13
Shares Outstanding (Mil)177.95

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 2,143 2,253
EBIT (Mil $) 165 275
EBITDA (Mil $) 357 419
EPS ($) 0.77 0.89
EPS without NRI ($) 0.77 0.89
EPS Growth Rate
(Future 3Y To 5Y Estimate)
16.77%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAN
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}